机构:[1]School of Life Science, University of Science & Technology of China, Hefei, 230027, Anhui, China[2]Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650201, China[3]Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China[4]The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, Hunan, China[5]The Third Affiliated Hospital, Kunming Medical University, Kunming, 650118, China[6]Department of Breast and Thyroid Surgery, Southwest Hospital, The First Affiliated Hospital of the Army Military Medical University, Chongqing, 400038, China[7]Department of the Pathology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China医技科室病理科昆明医科大学附属第一医院[8]Academy of Biomedical Engineering, Kunming Medical University, Kunming, 650500, China
This work was supported by the National Key R&D Program of China (No.2020YFA0112300), the National Natural Science Foundation of China (N0.82160461, 81830087, U2102203, and 81973160), the Yunnan Fundamental Research Projects (No.202101AS070050), the Major Projects for Fundamental Research of Yunnan Province (202201BC070002), and the Hunan Provincial Department of Education Fund (No.20A373, China).
第一作者机构:[1]School of Life Science, University of Science & Technology of China, Hefei, 230027, Anhui, China[2]Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650201, China
共同第一作者:
通讯作者:
通讯机构:[2]Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650201, China[5]The Third Affiliated Hospital, Kunming Medical University, Kunming, 650118, China[8]Academy of Biomedical Engineering, Kunming Medical University, Kunming, 650500, China[*1]Academy of Biomedical Engineering, Kunming Medical University, Kunming, 650500, China.
推荐引用方式(GB/T 7714):
Wang Luzhen,Mi Dazhao,Hu Jinhui,et al.A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer[J].CANCER LETTERS.2023,555:doi:10.1016/j.canlet.2022.216049.
APA:
Wang Luzhen,Mi Dazhao,Hu Jinhui,Liu Wenjing,Zhang Yi...&Chen Ceshi.(2023).A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.CANCER LETTERS,555,
MLA:
Wang Luzhen,et al."A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer".CANCER LETTERS 555.(2023)